These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24028324)

  • 1. Peanut Allergen Threshold Study (PATS): validation of eliciting doses using a novel single-dose challenge protocol.
    Zurzolo GA; Allen KJ; Taylor SL; Shreffler WG; Baumert JL; Tang ML; Gurrin LC; Mathai ML; Nordlee JA; Dunngalvin A; Hourihane JO
    Allergy Asthma Clin Immunol; 2013 Sep; 9(1):35. PubMed ID: 24028324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peanut Allergen Threshold Study (PATS): Novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy.
    Hourihane JO; Allen KJ; Shreffler WG; Dunngalvin G; Nordlee JA; Zurzolo GA; Dunngalvin A; Gurrin LC; Baumert JL; Taylor SL
    J Allergy Clin Immunol; 2017 May; 139(5):1583-1590. PubMed ID: 28238744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies.
    DunnGalvin A; Fleischer DM; Campbell DE; O'B Hourihane J; Green TD; Sampson HA; Greenhawt M
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):216-224.e1. PubMed ID: 32841748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using data from food challenges to inform management of consumers with food allergy: A systematic review with individual participant data meta-analysis.
    Patel N; Adelman DC; Anagnostou K; Baumert JL; Blom WM; Campbell DE; Chinthrajah RS; Mills ENC; Javed B; Purington N; Remington BC; Sampson HA; Smith AD; Yarham RAR; Turner PJ
    J Allergy Clin Immunol; 2021 Jun; 147(6):2249-2262.e7. PubMed ID: 33571537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender, prick test size and rAra h 2 sIgE level may predict the eliciting dose in patients with peanut allergy: Evidence from the Mirabel survey.
    Elegbede CF; Papadopoulos A; Just J; Moneret-Vautrin DA; Deschildre A; Crépet A
    Clin Exp Allergy; 2019 May; 49(5):677-689. PubMed ID: 30689235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The distribution of individual threshold doses eliciting allergic reactions in a population with peanut allergy.
    Wensing M; Penninks AH; Hefle SL; Koppelman SJ; Bruijnzeel-Koomen CA; Knulst AC
    J Allergy Clin Immunol; 2002 Dec; 110(6):915-20. PubMed ID: 12464959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose oral challenges to validate eliciting doses in children with cow's milk allergy.
    Turner PJ; d'Art YM; Duca B; Chastell SA; Marco-Martin G; Vera-Berrios RN; Alvarez O; Bazire R; Rodríguez Del Río P; Vazquez-Ortiz M; Baumert JL; van Ree R; Mills CEN; Fernandez-Rivas M; Hourihane JO
    Pediatr Allergy Immunol; 2021 Jul; 32(5):1056-1065. PubMed ID: 33608940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated population minimal eliciting dose distributions for use in risk assessment of 14 priority food allergens.
    Remington BC; Westerhout J; Meima MY; Blom WM; Kruizinga AG; Wheeler MW; Taylor SL; Houben GF; Baumert JL
    Food Chem Toxicol; 2020 May; 139():111259. PubMed ID: 32179163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
    O'B Hourihane J; Beyer K; Abbas A; Fernández-Rivas M; Turner PJ; Blumchen K; Nilsson C; Ibáñez MD; Deschildre A; Muraro A; Sharma V; Erlewyn-Lajeunesse M; Zubeldia JM; De Blay F; Sauvage CD; Byrne A; Chapman J; Boralevi F; DunnGalvin A; O'Neill C; Norval D; Vereda A; Skeel B; Adelman DC; du Toit G
    Lancet Child Adolesc Health; 2020 Oct; 4(10):728-739. PubMed ID: 32702315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three peanut-allergic/sensitized phenotypes with gender difference.
    Just J; Elegbede CF; Deschildre A; Bousquet J; Moneret-Vautrin DA; Crepet A;
    Clin Exp Allergy; 2016 Dec; 46(12):1596-1604. PubMed ID: 27512923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy.
    Blumchen K; Beder A; Beschorner J; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Niggemann B; Wahn U; Beyer K
    J Allergy Clin Immunol; 2014 Aug; 134(2):390-8. PubMed ID: 24831438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Informing Risk Management for Patients With Cow's Milk Allergy Based on Threshold Dose Distributions Using Low-Dose Food Challenges.
    Katz Y; Melchior M; Elizur A; Nachshon L; Remington BC; Leshno M
    J Allergy Clin Immunol Pract; 2023 Apr; 11(4):1116-1122. PubMed ID: 36379407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peanut-allergic patients in the MIRABEL survey: characteristics, allergists' dietary advice and lessons from real life.
    Deschildre A; Elegbédé CF; Just J; Bruyère O; Van der Brempt X; Papadopoulos A; Beaudouin E; Renaudin JM; Crepet A; Moneret-Vautrin DA
    Clin Exp Allergy; 2016 Apr; 46(4):610-20. PubMed ID: 26588036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sesame eliciting and safe doses in a large sesame allergic population.
    Nachshon L; Westerhout J; Blom WM; Remington B; Levy MB; Goldberg MR; Epstein-Rigbi N; Katz Y; Elizur A
    Allergy; 2023 Dec; 78(12):3212-3220. PubMed ID: 37606275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cow's milk and egg protein threshold dose distributions in children tolerant to beef, baked milk, and baked egg.
    Valluzzi RL; Riccardi C; Arasi S; Piscitelli AL; Calandrelli V; Dahdah L; Fierro V; Mennini M; Fiocchi A
    Allergy; 2022 Oct; 77(10):3052-3060. PubMed ID: 35652800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Reaction Symptoms and Eliciting Dose With Health-Related Quality of Life in Children With Peanut Allergy.
    Hu A; Lloyd M; Loke P; Chebar Lozinsky A; O'Sullivan M; Quinn P; Gold M; Tang MLK
    J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3195-3202.e4. PubMed ID: 37423341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sleep deprivation and exercise on reaction threshold in adults with peanut allergy: A randomized controlled study.
    Dua S; Ruiz-Garcia M; Bond S; Durham SR; Kimber I; Mills C; Roberts G; Skypala I; Wason J; Ewan P; Boyle R; Clark A
    J Allergy Clin Immunol; 2019 Dec; 144(6):1584-1594.e2. PubMed ID: 31319102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergen-specific oral immunotherapy for peanut allergy.
    Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Threshold dose for peanut: Risk characterization based upon diagnostic oral challenge of a series of 286 peanut-allergic individuals.
    Taylor SL; Moneret-Vautrin DA; Crevel RW; Sheffield D; Morisset M; Dumont P; Remington BC; Baumert JL
    Food Chem Toxicol; 2010 Mar; 48(3):814-9. PubMed ID: 20034533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Threshold Dose Distribution in Walnut Allergy.
    Blankestijn MA; Remington BC; Houben GF; Baumert JL; Knulst AC; Blom WM; Klemans RJB; Taylor SL
    J Allergy Clin Immunol Pract; 2017; 5(2):376-380. PubMed ID: 28110058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.